Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-23 | ARS Pharmaceuticals, Inc. | Tanimoto Sarina
(CHIEF MEDICAL OFFICER) |
M | Common Stock | A | 130993 | $0.84 - $1.44 | $138,989 |
| 2024-04-23 | ARS Pharmaceuticals, Inc. | Lowenthal Richard E
(PRESIDENT AND CEO) |
M | Common Stock | A | 130993 | $0.84 - $1.44 | $138,989 |
| 2024-04-19 | ARS Pharmaceuticals, Inc. | Tanimoto Sarina
(CHIEF MEDICAL OFFICER) |
M | Common Stock | A | 188491 | $0.84 - $1.44 | $199,998 |
| 2024-04-19 | ARS Pharmaceuticals, Inc. | Lowenthal Richard E
(PRESIDENT AND CEO) |
M | Common Stock | A | 188491 | $0.84 - $1.44 | $199,998 |
| 2024-04-16 | ARS Pharmaceuticals, Inc. | Tanimoto Sarina
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 100000 | $9.28 - $9.28 | $928,005 |
| 2024-04-16 | ARS Pharmaceuticals, Inc. | Lowenthal Richard E
(PRESIDENT AND CEO) |
S | Common Stock | D | 100000 | $9.28 - $9.28 | $928,005 |
| 2024-04-09 | ARS Pharmaceuticals, Inc. | Tanimoto Sarina
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 100000 | $9.28 - $9.28 | $927,733 |
| 2024-04-09 | ARS Pharmaceuticals, Inc. | Lowenthal Richard E
(PRESIDENT AND CEO) |
S | Common Stock | D | 100000 | $9.28 - $9.28 | $927,733 |
| 2024-03-25 | ARS Pharmaceuticals, Inc. | Shah Rajeev M.
(Director) |
P | Common Stock | A | 1401299 | $9.06 - $9.79 | $13,289,409 |
| 2024-03-22 | ARS Pharmaceuticals, Inc. | Lowenthal Richard E
(PRESIDENT AND CEO) |
S | Common Stock | D | 97610 | $9.01 - $9.12 | $890,321 |
| 2024-03-22 | ARS Pharmaceuticals, Inc. | Tanimoto Sarina
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 97610 | $9.01 - $9.12 | $890,321 |
| 2024-03-19 | ARS Pharmaceuticals, Inc. | Lowenthal Richard E
(PRESIDENT AND CEO) |
S | Common Stock | D | 2390 | $9.00 - $9.04 | $21,571 |
| 2024-03-19 | ARS Pharmaceuticals, Inc. | Tanimoto Sarina
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 2390 | $9.00 - $9.04 | $21,571 |
| 2024-03-13 | ARS Pharmaceuticals, Inc. | Lowenthal Richard E
(PRESIDENT AND CEO) |
S | Common Stock | D | 100000 | $9.00 - $9.14 | $913,680 |
| 2024-03-13 | ARS Pharmaceuticals, Inc. | Tanimoto Sarina
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 100000 | $9.00 - $9.14 | $913,680 |
| 2024-02-29 | ARS Pharmaceuticals, Inc. | Tanimoto Sarina
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 3782 | $9.01 - $9.02 | $34,100 |
| 2024-02-29 | ARS Pharmaceuticals, Inc. | Lowenthal Richard E
(PRESIDENT AND CEO) |
S | Common Stock | D | 3782 | $9.01 - $9.02 | $34,100 |
| 2024-02-26 | ARS Pharmaceuticals, Inc. | Tanimoto Sarina
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 99478 | $9.01 - $9.02 | $897,367 |
| 2024-02-26 | ARS Pharmaceuticals, Inc. | Lowenthal Richard E
(PRESIDENT AND CEO) |
S | Common Stock | D | 99478 | $9.01 - $9.02 | $897,367 |
| 2023-05-17 | ARS Pharmaceuticals, Inc. | Tanimoto Sarina
(Chief Medical Officer) |
G | Common Stock | D | 4200000 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |